Philadelphia Attorneys New Jersey Attorneys Pennsylvania Lawyers Golomb & Honik P.C.

Capital One to Pay $32M To Exit Overdraft Fee MDL

By Nathan Hale

Law360, Miami (January 14, 2015, 9:45 PM ET) — The plaintiffs in multidistrict litigation alleging banks acted in bad faith by processing transactions in an order that would net them the most in overdraft fees moved Wednesday in Florida federal court for preliminary approval of a settlement with Capital One Bank NA worth more than $31.7 million.

The deal, which follows settlement agreements with several other banks named in the 2010 suit, was worked out following about two years of settlement discussions and two rounds of mediation discussions, according to the filing.  The four years of litigation in the case have included about 20 depositions and the production of more than 325,000 pages of documents and electronic files.

The plaintiffs described the agreement as “an outstanding result for the settlement class,” with the cash payment amounting to about 35 percent of the most likely maximum recovery the settlement class could have recovered through a trial.  They have requested a final approval hearing for May.

“The action involved sharply opposed positions on several fundamental legal questions, including whether Capital One breached its duty of good faith and fair dealing to its customers when it engaged in high-to-low posting, as well as the enforceability to a contractually abbreviated period for bringing claims,” the plaintiffs said in their filing.

Capital One failed three times to have its case dismissed on preemption grounds.  A Florida federal judge in June shut down the bank’s attempt to apply to its case a Ninth Circuit decision that similar charges against Wells Fargo & Co. were preempted by the National Bank Act.

The suits, which popped up all around the country in the late 2000’s, all took issue with banks’ practice of deducting money from accounts not in chronological order but based on the size of transactions, alleging it was designed to maximize the number of overdraft fees.  The bulk of the suits were clustered in Florida, where they mostly prevailed on class certification.

Some banks were able to compel arbitration based on provisions in their customer agreements, but those that were not — including JP Morgan Chase Bank NA, Bank of America NA, and TD Bank NA — have settled for tens or hundreds of millions of dollars.

Other recent settlements include M&T Bank’s agreement to pay $4 million and Synovus Financial Corp.’s proposed $3.9 million pact.

Under Wednesday’s settlement, which would release Capital One from all claims in the suit, the bank would pay more than $31.76 million into an escrow account within 14 days of preliminary approval and will also pay all fees and costs for the notice program and administration of the settlement.

Settlement class members who do not opt out will automatically receive pro-rated shares from the settlement fund.  The filing says that settlement class counsel and their experts have used Capital One’s data to determine which account holders were harmed by the high-to-low posting practice.

Class counsel will also seek service awards of $10,000 each for two class representatives in addition to the relief they receive under the settlement program.

Capital One has also agreed not to oppose class counsel’s request for attorneys’ fees up to 35 percent of the settlement fund, plus reimbursement of litigation costs and expenses, according to the filing.

The plaintiffs are represented by Podhurst Orseck PA, Bruce S. Rogow PA, Grossman Roth PA, Lieff Cabraser Heimann & Bernstein LLP, Baron & Budd PC, Webb Klase & Lemond LLC, Golomb & Honik PC and Trief & Olk, among others.

Capital One is represented by Jones Walker Waeschter Poitevent Carrere & Denegre LLP, Covington & Burling LLP and Morrison & Foerster LLP.

The case is In re: Checking Account Overdraft Litigation, case number 1:09-md-02036, in the U.S. District Court for the Southern District of Florida

–Additional reporting by Kate Greene, Paul DeBenedetto and Andrew Scurria.  Editing by Andrew Park.

Calif. Research Co. Not Paying Study Participants, Suit Says

By:  Jessica Corso

Law360, New York (February 06, 2015, 2:55 PM ET) — A California research company has been hit with a putative class action in a Los Angeles court accusing it of committing fraud and violating a state medical research law by failing to compensate study participants as promised.

Medicus Research LLC, which operates as Staywell Research, is putting up barriers to prevent study participants from collecting the pay they were promised when they agreed to participate in the research, according to a complaint filed Wednesday.

Lead plaintiff Francesca Gallard says she signed a contract, which Staywell refused to give her a copy of, that stated she would be paid $1,000 within 75 days of completing a weight loss study that entailed using a specific weight-loss powder and completing lengthy office visits twice a month.  That was in July of 2013 and Gallard Says she still has not received a dime.

She believes that thousands to tens of thousands of other Californians have met with the same resistnace by the company and its lead researcher, Dr. Sanjay K. Udani, based on customer complaints filed over the internet, with some unhappy participants even setting up a Facebook page dedicated to pursuing Staywell for the payments, according to the complaint.

“Plaintiffs are informed and believe defendants direct complaints from participants seeking owed compensation to a call center, which is rarely answered.  Defendants instruct representatives working the call center to not provide callers with information regarding compensaton,” according to the complaint.

Walk-in-requests for payment are also met with stalling tactics, Gallard says, and twenty complaints have already been filed against Staywell since Jan. 1 with the Business Consumer Alliance.

Aside from breaking contracts promising to pay the participants between $200 and $1,500, Staywell is also being accused of violating California Protection of Human Subjects in Medical ExperimentationAct by not obtaining informed consent.

The proposed class would never have consented to participate in the study without promises fround in the company’s marketing materials, including on its website, that participants would be paid, Gallard says.

Neither Staywell nor Medicus could be immediately reached to comment on the allegations Friday.

The proposed class is being represented by Gillian L. Wade andAllison K. Willett of Milstein Adelman LLP and Kenneth J. Grunfeld of Golomb & Honik PC.

Counsel information for defendants was not immediately available Friday.

The suit is Gallard et.al. v. Medicus Research LLC etal, case number BC571558, in the Superior Court of the State of California, Los Angeles County.

–Editing by Emily Kokoll.

Public Citizen Petitions FDA to Recall Fungal Drug Ketoconazole

The consumer advocacy group Public Citizen has recently petitioned the FDA to recall the fungal medication ketoconazole due to concerns over an increased risk of liver damage. In their statement to the FDA, Public Citizen made the following claims:

  • The risk of liver damage far outweighs the “questionable” benefits of this drug
  • The FDA sent an internal memo in 2013 that classified the risks associated with ketoconazole as intolerable
  • Back in 1983, the FDA had issued a black box warning, the highest safety concern they have, due to the potential for fatal liver damage

As recently as 2013, the FDA had issued a safety notice that limited the number of approved uses of ketoconazole on the product’s labeling due to the risk of liver damage, adrenal gland dysfunction, and a high risk of dangerous interactions with other drugs. Even with regards to the remaining approved uses of the drug – treatment of five different fungal infections – the FDA urged that ketoconazole only be used as a last resort. Ketoconazole has already been taken off the market in Europe due to these safety concerns.

The FDA is currently reviewing the Public Citizen petition and will hopefully make a decision shortly.

If you’ve suffered serious liver damage due to taking one of the generic forms of ketoconazole, you may be entitled to recover compensation for your damages. The pharmaceutical injury lawyers at Golomb & Honik have decades of experience handling these complex cases. They have the vast resources to take on the high powered legal teams employed by pharmaceutical companies, and they’ve earned lucrative verdicts and settlements on behalf of many drug injury victims.

Please contact Golomb & Honik using the form at the left side of the page or call 855-889-5389 today to schedule your free drug injury consultation. We serve clients nationwide from our offices in Philadelphia, Pennsylvania.

A Large Number of Vehicle Recalls Expected in 2015

There were an unprecedented number of vehicle recalls in 2014, prompting many experts to call it “The Year of the Recall.” While the number of recalls in 2015 isn’t expected to match the record 63.9 million vehicles recalled in 2014, a recent study presented at the Automotive Warranty and Recall Symposium predicts another above average year.

According to the study, the main reason for this continued increased number of vehicle recalls is that the federal government is becoming more effective at identifying vehicle issues that need to be fixed via recall. Overall, this is a good sign for the improvement of vehicle safety moving forward.

Based in the report, it’s unlikely that we’ll see another year where one or two large issues dominate the recalls. Last year, defective Takata airbags comprised nearly 30% of all recalls, while GM ignition switch defects accounted for 20% of recalls. Instead, it’s expected that 2015 will see a larger number of recalls issued, but for smaller numbers of vehicles per recall.

The head of the National Highway Traffic Safety Administration (NHTSA) mirrored the sentiments expressed by the report. “I think we could actually see an increase in the number of recalls. The reality is that means your system is working….I’d rather have people be preemptive than waiting too long and making a mistake, because you can’t save those lives after they’re gone.”

The NHTSA received $126 million in fines and penalties from vehicle manufacturers in 2014. This figure is more than the total amount they’ve collected in all other years combined, providing further evidence that the NHTSA is cracking down on vehicle safety issues.

If you’ve been injured a car accident caused by a defective auto, you may be entitled to recover compensation for your damages. The attorneys at Golomb & Honik have decades of experience handling defective auto claims, and we have the vast resources to hold negligent auto manufacturers accountable for their actions.

Please contact Golomb & Honik using the form at the left side of the page or call 855-889-5389 today to schedule your defective auto consultation. We serve clients nationwide from our offices in Philadelphia, Pennsylvania.

Judge Upholds $1.75 Million Punitive Damage Award in Transvaginal Mesh Case

A federal judge denied a motion to reduce the $1.75 million punitive damage award against C.R. Bard Inc., the manufacturer of the Avaulta Plus transvaginal mesh device used to treat pelvic organ prolapse and stress urinary incontinence. The judge ruled to uphold the large punitive damage award since evidence demonstrated that Bard knew their transvaginal mesh product was dangerous, yet did nothing about it.

According to evidence presented in the trial, Bard knew that the polypropylene resin used to manufacture their transvaginal mesh device was dangerous because Phillips company, the makers of the resin material, explicitly warned Bard that it shouldn’t be used in permanently implanted medical devices. Phillips even refused to sell the material to Bard due to these risks. However, Bard purchased the resin from a different company and intentionally kept this fact a secret from Phillips.

Bard eventually stopped contacting the new supplier directly because the supplier refused to sell the resin material to Bard after learning it was being used in a dangerous way. In addition, evidence demonstrated that Bard:

  • Ignored recommendations from doctors and researchers stating that additional trials were needed before taking this product to market
  • Disregarded adverse results obtained on the tests that were conducted on their transvaginal mesh product, and failed to communicate these adverse results to doctors

Based on all of this evidence, the judge ruled that the high punitive damage award was appropriate due to Bard’s reckless disregard of information demonstrating their product’s potential to harm patients.

Bard is still facing several other class action lawsuits associated with their defective transvaginal mesh device. If you’ve suffered an injury due to this defective medical device, you may be entitled to compensation for your damages. The attorneys at Golomb & Honik have decades of experience handling these complex claims, and we have the vast resources necessary to achieve a successful outcome through litigation.

Please contact Golomb & Honik using the form at the left side of the page or call 855-889-5389 today to schedule your defective transvaginal mesh consultation. We serve clients nationwide from our offices in Philadelphia, Pennsylvania.

2.1 Million Vehicles Recalled for Second Time

The National Highway Traffic Safety Administration (NHTSA) announced a recall of 2.1 million Toyota, Chrysler, and Honda vehicles to correct issues associated with a defect that results in an unintentional deployment of airbags when there is no car accident.

This is actually the second time these vehicles have been recalled for this defect. The first recall occurred between 2012 and 2014, but as many as 40 of these vehicles have been reported to still exhibit the defect after the initial recall. As a result, this new recall was initiated for precautionary measures.

The new recall covers the following vehicle models:

  • Acura MDX
  • Dodge Viper
  • Jeep Grand Cherokee
  • Jeep Liberty
  • Honda Odyssey
  • Pontiac Vibe
  • Toyota Corolla
  • Toyota Matrix
  • Toyota Avalon

Vehicle owners will be notified of the recall shortly. You can learn more information by contacting your local dealer.

If you’ve been injured as a result of one of these defective autos, you may be entitled to receive compensation for your damages. The attorneys at Golomb & Honik have decades of experience handling defective vehicle claims, and we’ll fight aggressively to protect your rights in court.

Please contact Golomb & Honik using the form at the left side of the page or call 855-889-5389 today to schedule your defective auto consultation. We serve clients nationwide from our offices in Philadelphia, Pennsylvania.

 

Anesthesia Errors

All surgery carries certain risks including infection, anesthesia problems and death. Anesthesia errors are particularly catastrophic, and the result is often fatal. While rare considering how many surgeries are performed each year in the United States, anesthesia errors do occur. If you or your loved one has suffered harm due to an error in anesthesia, you may be entitled to monetary compensation.

Most people are aware that general anesthesia carries significant risks because it renders patients unconscious and completely dependent on others to keep them alive. While typically less risky than general anesthesia, regional and local anesthesia can also be dangerous, and errors in administration can cause serious injury.

Anesthesia errors and the harm that they cause are preventable. In some cases they are the result of inadequate product labeling or defective equipment, but in most cases they are the result of medical malpractice.

Those who survive anesthesia errors may need extensive treatment to recover or may be permanently disabled, unable to work, and require life-long care. Victims of anesthesia awareness can suffer severe psychological and emotional damage that may or may not respond to therapy. This can lead to serious health problems and even death when patients are so terrified that they will no longer seek medical care under any circumstances.

If you or a loved one has been the victim of an anesthesia error, please contact Golomb & Honik using the form at the side of the page or call 855-889-5389 today to schedule your free medical malpractice consultation. Golomb & Honik serve clients nationwide from our offices in Philadelphia, Pennsylvania.

Types of Cerebral Palsy

Cerebral palsy (CP) can affect your child’s life in many different ways and degrees of severity depending on the type and the part of the body that is affected. Your child’s chance of recovering and living a normal life is largely dependent on the treatments you can afford. When cerebral palsy is the result of medical malpractice, just compensation can mean access to the best and newest treatments available.

 

In spastic CP, the muscles are too tight; spastic CP can affect just one limb or the entire body. When the entire body is affected, there is a high likelihood of mental retardation and seizures.

 

Ataxic CP causes the muscles to be too weak creating problems with balance, walking, and motor skills.

 

Athetoid CP results in the muscle fluctuation from being too tight to too weak. Some muscles can be too tight at the same time as others are too weak. The result is involuntary movements. This type of cerebral palsy can be so severe that your child cannot sit upright on his own. Athetoid CP does not cause cognitive impairment.

 

Mixed CP is common and simply means that there are symptoms of more than one type.

 

The type of CP a child develops and the parts of the body that are affected depend on the area of the brain that is injured. Only about 50% or less of children with CP experience cognitive impairment, but when motor skills are severely impaired, accurate testing of cognitive skills can be very difficult.

 

If you suspect that your child’s cerebral palsy may be the result of medical malpractice and you live in the Philadelphia, Pennsylvania area, please contact Golomb & Honik using the form on the left side of the page or call 855-889-5389 today to schedule your free consultation.

Detecting Birth Injuries

In some cases, a birth injury can be caused by the natural birthing process. Other times, it is the result of medical negligence on the part of the obstetric professionals. The problem with birth injuries is that some are immediately evident, and others may not be diagnosed until days or even years after your child’s birth.

The types of birth injuries that are most apparent immediately following the birth of your child include:

  • Lacerations
  • Forcep marks
  • Swelling of the scalp
  • Facial paralysis
  • Bruises
  • Fractures
  • Subconjunctival hemorrhage (ruptures to the tiny blood vessels in your child’s eye)

Sadly, severe injuries like Cerebral Palsy or Erb’s Palsy may not surface until later in your child’s life.

Many potential birth injuries and other serious conditions can be detected with a simple blood test or through an ultrasound. The most common prenatal screening tests look for markers or evidence of the following:

  • Cystic Fibrosis
  • Sickle Cell Disease
  • Tay-Sachs Disease
  • Canavan’s Disease
  • Down syndrome
  • Spina bifida

Your doctors, nurses and obstetricians owe you a certain standard of care. If your baby was born with an injury that could have been prevented or detected through proper screening, you deserve to be fairly compensated. Not because money will necessarily heal your new baby right away, but because their birth injury will likely require extensive and long-term medical care and that is expensive. Your child and your family should not have to struggle because of someone else’s negligence.

If you believe your child has suffered a birth injury, please contact Golomb & Honik using the form on the left side of the page or call 855-889-5389 today to schedule your free medical malpractice consultation. Golomb & Honik serve clients nationwide from our offices in Philadelphia, Pennsylvania.

 

 

Class Action Lawsuit Filed Against Four Connecticut Energy Providers

Four Connecticut power companies have been accused of over-charging consumers, and have recently had a class action lawsuit filed against them. The companies are Discount Power, Viridian Energy, North American Power and Direct Energy, and are being charged with deceptive practices. The lawsuit alleges that four power companies made claims in the contracts they entered into with consumers to the effect that the variable power rates will go up and down, depending on the wholesale cost of electricity. Instead, even when the wholesale prices dropped, the power companies continued to charge customers higher kilowatt hour rates—in some cases as much as five times the wholesale price.

Power Companies Offered “Teaser Rates”

Consumers in Connecticut are given a choice of power companies for their home, and many chose to stay with Connecticut Light and Power. Other consumers, who might be having trouble paying their power bills, were lured to other power suppliers who promised lower rates. The suppliers buy and re-sell energy for a profit, but it appears the profits received by the four power companies were much higher than they deserved—at a cost to their consumers.

The lawsuit claims the companies offered what is known as a “teaser rate,” which they put into effect for a few short months. When the teaser rate expired, it automatically shifted to a variable rate, causing the prices to skyrocket. Only one of the power companies involved in the class-action suit responded to requests for comment. A North American Power spokesman stated the lawsuit has no merit and that their company consistently provides written notice to consumers when the variable rate is about to go into effect.

Class-Action Lawsuits against Other Power Companies Filed Earlier

This lawsuit follows closely on the heels of another class action lawsuit filed against Connecticut-based electric company, Starion Energy in the amount of $50 million. The Starion lawsuit was filed in the U.S. District Court for the Southern District of New York on behalf of consumers who had been promised significant savings on their energy bills if they switched from the current energy supplier to Starion. After the customers switched companies, they found the rates they were being charged were two to three times the rates they had been quoted.

Starion Energy has a pattern of deceptive sales practices; in early 2014 the Maryland Public Service Commission determined the company had a pattern of misrepresentation toward potential customers. While Starion received a fine, they continued to perpetrate the fraud against consumers, particularly elderly consumers who were having trouble paying their power bills.

De-regulation of the Electric Energy Benefitted Suppliers

Many energy suppliers benefitted when the electric industry was deregulated, and Starion Energy was no exception. Starion has more than 30,000 customers in Connecticut alone, with thousands more in seven additional states, and is one of the fastest-growing energy suppliers in the United States.

The Starion lawsuit was filed in early November and has been given several weeks to respond to allegations. The Starion lawsuit asks for a jury trial, triple the amount of damages, compensatory damages, and an order to stop Starion from perpetrating further deception on consumers.

Hiko Energy, Palmco Power New Jersey, Keil & Sons, and Palmco Energy New Jersey all have similar lawsuits pending against them.  The Hiko Energy lawsuit filed by the lawyers at Golomb & Honik, P.C. in particular, claims that consumers were promised a ten percent reduction in monthly bills for the first six months—instead their bills immediately went up. Hiko customers were given no avenue for reaching the company with their complaints, and no way to terminate their contracts.

The recent class action suit against Discount Power, Viridian Energy, North American Power and Direct Energy has not been answered by the power companies, and many consumers are anxiously awaiting just how the companies will justify the increases in monthly bills.

Contact National Consumer Protection Lawyers

If your electricity rates have increased suddenly after switching to a different service provider, you may have cause to file a claim. The lawyers at Golomb & Honik are actively litigating consumer complaints of rate spikes by deceptive and fraudulent electric companies. For a free review of your case, call the Pennsylvania consumer protection lawyers at Golomb & Honik today at 1-800-355-3300 or 1-215-985-9177 or fill out our confidential Contact Form.

 

The consumer protection lawyers at Golomb & Honik have successfully represented individuals in Philadelphia, Pennsylvania, New Jersey, and throughout the United States.

 

Golomb & Honik

215.985.9177 | 855.889.5389

1515 Market Street , Suite 1100 Philadelphia, PA 19102